{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-041436","form_type":"8-K","ticker":"OCEA","cik":"0001869974","company_name":"Ocean Biomedical, Inc.","filed_at":"2024-10-17T23:59:59+00:00","discovered_at":"2026-05-14T18:03:10.193379+00:00","generated_at":"2026-05-30T13:26:58.813998+00:00","sec_items":["1.01","9.01"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Ocean Biomedical ratifies revised Virion agreement to acquire up to 22% stake for $9M","bullets":["Board ratified revised agreement dated Nov 2023, received Sep 26, 2024; Ocean to own 22% of Virion fully diluted.","$9M aggregate capital contribution paid via cash and/or equity; $960k already credited.","Virion will sell 500,000 OCEA shares held; proceeds count toward $9M.","If proceeds below $9M by Apr 1, 2025, Ocean may pay difference in cash or stock.","Max common interests: 10,933,155; initial 1,166,203 already issued (2.34% as of Aug 21, 2024)."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-041436","json":"https://secwatch.observer/filing/0001493152-24-041436.json","markdown":"https://secwatch.observer/filing/0001493152-24-041436.md","text":"https://secwatch.observer/filing/0001493152-24-041436.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1869974/000149315224041436/0001493152-24-041436-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1869974/000149315224041436/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T13:26:58.813998+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}